Abstract
In the present study, we have reported the synthesis of some novel heterocyclic derivatives comprising imidazole and 1,3,4-thiadiazole containing moiety. Imidazothiadiazoles are of interest because of their diverse biological activities and clinical applications. Reactions of biphenyl carboxylic acid with thiosemicarbazide in the presence of phosphorous oxychloride resulted in biphenyl containing 2-amino-1,3,4-thiadiazole which is then further subjected to condensation with α-bromoarylketone under reflux in dry ethanol. The structures of the newly synthesised compounds were characterized by various spectral techniques and screened for antibacterial activity against strains of Escherichia coli, Pseudomonas aeruginosa and Bacillus subtilis, and antifungal activity against Candida albicans, Saccharomyces cerevisiae and Aspergillus niger. The compounds exhibited moderate to good activity when compared with standards.
References
Khazi IAM, Gadad AK, Lamani RS and Bhongade BA, Chemistry of imidazo[2,1-b][1,3,4]thiadiazoles. Tetrahedron (2011) 67: 3289-16.
Alagawadi KR and Alegaon SG, Synthesis, characterization and antimicrobial activity evaluation of new 2,4-thiazolidinediones bearing imidazo[2,1-b][1,3,4]thiadiazole moiety. Arabian J. Chem. (2011) 4: 465-72. (doi:10.1016/j.arabjc.2010.07.012).
Tenover FC and McDonald LC, Vencomycin-resistant Staphylococcus and Enterococci: Epidemiology and control. Curr. Opin. Infect. Dis. (2005)18: 300-05.
Pfeltz RF and Wilkinson BJ, Autolytic properties of glycopeptides-intermediate Staphylococcus aureus Mu50. Curr. Drug Targets Infect. Disord. (2004) 4: 273-94.
Roberts MC, Distribution of macrolide, lincosamide, streptogramin, ketolide and oxazolidinone (MLSKO) resistance genes in gram negative bacteria. Curr. Drug Targets Infect. Disord. (2004) 4: 207-15.
Dessen A, Di Guilmi AM, Vernet T and Dideberg O, Molecular mechanism of antibiotic resistance in gram positive pathogens. Curr. Drug Targets Infect. Disord. (2001) 1: 63-77.
Muroi H, Nihei K, Tsujimoto K and Kubo I, Synergistic effects of anacardic acids and methicillin against methicillin-resistant Staphylococcus aureus. Biorg. Med. Chem. (2004)12: 583-87.
Chopra I, Schofield C, Everett M, O’Neill K, Miller K and Wilcox M, Treatment of health care associated infections caused by gram negative bacteria: a consensus statement. Lancet Infect. Dis. (2008) 8: 133-39.
Terzioglu N and Gursoy A, Synthesis and anticancer evaluation of some new hydrazone derivatives of 2,6-dimethylimidazo[2,1-b][1,3,4]thiadiazole-5-carbohydrazide. Eur. J. Med. Chem. (2003) 38: 781-86.
Gadad AK, Noolvi MN and Karpoormath RV, Synthesis and anti-tubercular activity of a series of 2-sulfonamide/trifluoromethyl-6-substituted imidazo [2,1-b][1,3,4] thiadiazole derivatives. Bioorg. Med. Chem. (2004)12: 5651-59.
Gadad AK, Mahajanshetti CS, Nimbalkar S and Raichurkar A, Synthesis and antibacterial activity of some 5-guanylhydrazone/thiocyanato-6-arylimidazo[2,1-b]-1,3,4-thiadiazole-2-sulfonamide derivatives. Eur. J. Med. Chem. (2000) 35: 853-57.
Andotra CS, Langer TC and Kotha A, Synthesis and antifungal activity of some substituted 1,3,4-thiadiazolo[3,2-a]-s-triazin-5-phenyl-7-thiones and imidazo-[2,1-b]-1,3,4-thiadiazol-5-ones. J. Indian. Chem. Soc. (1997) 74: 125-27.
Khazi IAM, Mahajanshetti CS, Gadad AK, Tarnalli AD and Sultanpur CM, Synthesis and anticonvulsant and analgesic activities of some 6-substituted imidazo[2,1-b][1,3,4]thiadiazole-2-sulfonamides and their 5-bromo derivatives. Arzneim-Forsch./Drug. Res. (1996) 46: 949-52.
Andreani A, Leonia A, Locatelli A, Morigi R, Rambaldi M, Simon WA and Senn-Bilfinger J, Synthesis and antisecretory activity of 6-substituted 5-cyanomethyl imidazo[2,1-b]thiazoles and 2,6-dimethyl-5-hydroxymethylimidazo [2,1-b][1,3,4]thiadiazole. Arzneim-Forsch./Drug. Res. (2000) 50: 550-53.
Banu A, Vasundhara DE, Lamani RS, Khazi IAM and Begum NS, Synthesis, spectroscopic and crystal structure Analysis of 2-(4-fluorobenzyl)-6-(4-methoxyphenyl)imidazo[2,1-b][1,3,4]thiadiazole and its morpholinomethyl derivative. J. Saudi. Chem. Soc. (2011) (doi:10.1016/j.jscs.2011.03.010).
Karki SS, Panjamurthy K, Kumar S, Nambiar M, Ramareddy SA, Chiruvella KK and Raghavan SC, Synthesis and biological evaluation of novel 2-aralkyl-5-substituted-6-(4'-fluorophenyl)-imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent anticancer agents. Eur. J. Med. Chem. (2011) 46: 2109-16.
Lamani RS, Shetty NS, Kamble RR and Khazi IAM, Synthesis and antimicrobial activity of novel methylene bridged benzisoxazolyl imidazo[2,1-b][1,3,4]thiadiazole derivatives. Eur. J. Med. Chem. (2009) 44: 2828-33.
Gadad AK, Palkar MB, Anand K, Noolvi MN, Boreddy TS and Wagwade J, Synthesis and biological evaluation of 2-trifluoromethyl/sulfonamide-5,6-diaryl substituted imidazo[2,1-b]-1,3,4-thiadiazoles: A novel class of cyclooxygenase-2 inhibitors. Bioorg. Med. Chem. (2008) 16: 276-83.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array